Trial
NCT04588441
The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19
Phase IIWITHDRAWNREGULATORYConfidence: HIGH
Sponsor
University of Florida
Collaborators
—
Condition
Acute Respiratory Distress
Intervention
Adenosine
Why stopped
Study never started due to need for additional preclinical work requested by FDA\>
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-06